- Analysts
- Dividend Payments
- Government Awards
- Insiders
- Lobbying Expenses
- Segment Revenues
- Shareholder Structure
- Supply / Portfolio
- Valuation Models [Soon]
- Board & Officers
- Business Intelligence
- Employee Voice
- ESG Scores [Soon]
- Mergers and Acquisitions
- Qualified Risks
- Clinical Trials [Soon]
- H1B/PERM Strategy
- Industry H&T [Soon]
- Macro
- News
- Patents / Trademarks [Soon]
- Peer Performance
- Relevant Disputes [Soon]
Artivion, Inc.
Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurol…
Shareholders
Major Shareholders · StructureBreakdown
The breakdown presents the total weighting of the relevant parties: Institutes, Insiders & Public. for Artivion, Inc.
Beneficial Owners Beta
Beneficial owners who control a significant portion of the shares outstanding.
Owner | Shares | Equivalence - $30.06 per share | Last Form/Filing | Last Transaction |
---|---|---|---|---|
10% Holder | ||||
- No data - | ||||
Officers/Directors Below 10% | ||||
Internal : VP, Chief Accounting Officer
|
122,711 | $3,688,692.66 |
S
1,329 x $18.86 =
$25,064.94
|
|
Internal : SVP, General Counsel
|
157,897 | $4,746,383.82 |
S
4,035 x $30.25 =
$122,058.75
|
|
Internal : VP Regulatory
|
36,667 | $1,102,210.02 |
A
11,100 x $0 =
$0
|
|
Internal : VP, Human Resources
|
48,503 | $1,458,000.18 |
S
1,157 x $18.72 =
$21,659.04
|
|
Internal : Director
|
34,159 | $1,026,819.54 |
S
9,709 x $24.99 =
$242,627.91
|
|
Internal : Director
|
143,571 | $4,315,744.26 |
A
6,289 x $0 =
$0
|
|
Internal : Director
|
143,736 | $4,320,704.16 |
A
6,289 x $0 =
$0
|
|
Internal : Director
|
123,515 | $3,712,860.90 |
A
6,289 x $0 =
$0
|
|
Internal : Director
|
62,322 | $1,873,399.32 |
A
6,289 x $0 =
$0
|
|
Internal : Director
|
47,471 | $1,426,978.26 |
A
6,289 x $0 =
$0
|
|
Internal : Director
|
42,763 | $1,285,455.78 |
A
6,289 x $0 =
$0
|
|
Internal : Director
|
25,064 | $753,423.84 |
A
6,289 x $0 =
$0
|
|
Internal : SVP, Clinical & MD Affair
|
53,903 | $1,620,324.18 |
A
565 x $14.61 =
$8,254.65
|
|
Internal : President & CEO
|
705,562 | $21,209,193.72 |
S
13,996 x $18.72 =
$262,005.12
|
|
Internal : Chief Commercial Officer
|
161,935 | $4,867,766.10 |
S
584 x $19.83 =
$11,580.72
|
|
Internal : VP, Quality
|
29,123 | $875,437.38 |
S
407 x $18.86 =
$7,676.02
|
|
Internal : VP, Global Operations
|
22,790 | $685,067.40 |
A
6,537 x $0 =
$0
|
|
Internal : Executive VP, CFO
|
79,064 | $2,376,663.84 |
A
37,000 x $0 =
$0
|
|
Internal : VP Research & Development
|
13,291 | $399,527.46 |
A
8,165 x $0 =
$0
|
Shareholder Breakdown
The breakdown presents the total weighting of the relevant parties: Institutes, Insiders & Public.
It's perfect to get a quick briefing regarding the shareholder structure of Artivion, Inc.
Short
We source Fail-To-Deliver data every month, directly from the SEC.